U.S. Capital Wealth Advisors’s Allied Healthcare Products AHPI Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio AHPI Stock Details AHPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$465	–	1618
2022 Q4	$465	Buy	+500	New	+$589	﹤0.01%	1571

U.S. Capital Wealth Advisors's AHPI Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Allied Healthcare Products (AHPI) in Q1 2023, closing a stake of 500 shares — an estimated $465 sold.

U.S. Capital Wealth Advisors first reported a position in AHPI in Q4 2022 and held it in 1 quarter. The position peaked at $465 in Q4 2022. 1 fund tracked by Wall St. Rank holds AHPI as of Q1 2023.

U.S. Capital Wealth Advisors reported no remaining Allied Healthcare Products position as of Q1 2023 after selling out during the quarter.
U.S. Capital Wealth Advisors sold 500 Allied Healthcare Products shares in Q1 2023, an estimated $465.
U.S. Capital Wealth Advisors first reported a position in Allied Healthcare Products in Q4 2022 and held it in 1 quarter.
U.S. Capital Wealth Advisors's Allied Healthcare Products position peaked at $465 in Q4 2022.
1 fund tracked by Wall St. Rank held Allied Healthcare Products as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.